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Long-term in vitro maintenance of embryonic stem cell (ESC) pluripotency enables the pluripotency and differentiation of 
ESCs in animals to be investigated. The ability to successfully maintain and differentiate chicken embryonic stem cells (cESCs) 
would provide a useful tool for avian biology research and would be a resource directly applicable to agricultural production. 
In this study, endogenous chicken pluripotency transcription factors, POUV, Sox-2, Nanog and Lin28 were cloned and ex-
pressed as recombinant proteins containing a nine consecutive arginine protein transduction domain (PTD). cESCs were cul-
tured with these recombinant proteins to maintain cESC pluripotency in vitro. Cultured cESCs exhibited typical characteristics 
of pluripotency, even after six generations of rapid doubling, including positive staining for stage-specific embryonic antigen I, 
and strong staining for alkaline phosphatase. Expression levels of the pluripotency markers, POUV, Nanog, C-Myc, Sox-2 and 
Lin28 were the same as in uncultured stage X blastoderm cells, and most significantly, the formation of embryoid bodies (EBs) 
by 6th generation cESCs confirmed the ability of these cultured cESCs to differentiate into cells of all three embryonic germ 
layers. Thus, transcription factors could be translocated through the cell membrane into the intracellular space of cESCs by us-
ing a PTD of nine consecutive arginines and the pluripotency of cESCs could be maintained in vitro for at least six genera-
tions. 
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Embryonic stem cells (ESCs) have been intensively re-
searched since they were first derived from the inner cell 
mass (ICM) of mouse blastocysts in 1981 [1,2], and ESCs 
from many species have now been derived. Chickens are an 
important agricultural poultry species and also a vital ani-
mal research model for many biological processes. Chicken 
ESCs (cESCs) have been demonstrated to have pivotal util-
ity in transgenic poultry production, bird species conserva-
tion, and medical protein production [3]. The X stage blas-
toderm of chickens is the source of cESCs [3]. Cells sepa-
rated from the X stage blastoderm of chickens exhibit typi-
cal ESC characteristics, including: positive staining for al-
kaline phosphatase (AKP) and stage-specific embryonic 
antigen I (SSEA-I), expression of pluripotency factors, such 
as POUV, Nanog, C-Myc, Sox-2 and Lin28, and differenti-
ation potential toward all three embryonic germ layers via 
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EB formation in vitro or chimera animal production in vivo 
[35]. Previous studies of cESCs have developed their po-
tential, including the introduction of feeder cells, the em-
ployment of mouse and human cytokines and growth factors, 
and the cloning and functional studies of chicken cytokines, 
such as leukocyte inhibitory factor (LIF), and pluripotency 
genes, such as POUV and Nanog [3,4,6]. Although some 
culture methods have reported several generations of cESCs 
in vitro, these results could not be reliably reproduced, in-
dicating unstable experimental protocols [6–8]. Develop-
ment of a practical, stable, and reproducible long-term cul-
tured cESC line is still a big challenge. Unlike for mice and 
humans, an in vitro chicken ESC culture line has not yet 
been reported [2,9], indicating the differences of ESC char-
acteristics among species. 
The pluripotency state of ESCs has been intensively 
studied and there is a significant, although incomplete, un-
derstanding of pluripotency at the molecular level. Research 
on induced pluripotency stem cells (iPSCs) has provided a 
new avenue and methodology to detect and understand the 
molecular mechanism of pluripotency in ESCs, in addition 
to highlighting the functions of pluripotency factors [10]. 
While some problems have been addressed using this tech-
nique, the safety of iPSC generation has been a significant 
concern because of the viral-mediated method used to gen-
erate iPSCs; the risk of reactivation from pseudotype virus 
back to wide-type virus has not been totally eliminated 
[11,12]. The inconvenient and troublesome procedures as-
sociated with this DNA insertion method have been another 
limitation because results are difficult to replicate and can 
be unstable. Thus, many studies have been performed to 
develop new methods [1315].  
The protein transduction domain (PTD) is a short peptide 
composed of part of the HIV-1 Tat sequence or a peptide of 
consecutive hydrophobic amino acids. Previous medical and 
pharmacological studies have demonstrated the high effi-
ciency of PTDs as a means to quickly deliver macromole-
cules through cell membranes into the intracellular space of 
target cells [1619].  
Reports from two research groups provided a method for 
iPSC generation free of DNA insertion based on recombi-
nant pluripotency proteins fused with a PTD consisting of 9 
or 11 consecutive arginines [20,21]. This made iPSC gener-
ation safe and convenient: it established a stable tool for 
ESC research, and suggested the possibility of using plurip-
otency factors in ESC cultures. Although there has not been 
an iPSC line generated for chicken, the attractive and pow-
erful functions of pluripotency factors should be investigat-
ed in ESCs of different species. These pluripotency factors 
can re-establish pluripotency from the differentiated state; 
however, it is not known whether they prevent pluripotency 
from being lost. Here, we aim to determine if pluripotency 
factors in the form of recombinant proteins with a PTD can 
maintain the pluripotency of cESCs cultured in vitro. 
1  Materials and methods 
1.1  Plasmid construction  
1.1.1  pEGFP9R 
Primers to PCR amplify EGFP coding sequence (CDS) 
were designed. Nine consecutive arginines at the 5′ end of 
the antisense primer and restriction endonuclease sites at the 
5′ end of both sense and antisense primers were incorpo-
rated. pEGFP-NI was used as a template. PCR products 
were subcloned into pEGFP-NI, from which the EGFP se-
quence has been removed, resulting in the plasmid 
pEGFP9R. 
1.1.2  pPF9R-IRES 
Primers to PCR amplify CDSs of pluripotency proteins, 
POUV-9R, Sox-2-9R, Nanog-9R and Lin28-9R were de-
signed incorporating nine consecutive arginines at the 5′ end 
of the antisense primers and restriction endonuclease sites at 
the 5′ end of both sense and antisense primers. POUV, 
Sox-2, Nanog and Lin28 CDS were amplified by RT-PCR 
from cESCs total RNA using these primers. PCR products 
were subcloned into pEGFP-IRES2, resulting in pPF9R- 
IRES plasmids, including pPOUV9R-IRES, pSox-2-9R- 
IRES, pNanog9R-IRES and pLin28-9R-IRES.  
1.2  Evaluation of the efficiency of the nine consecutive 
arginine PTD in translocating exogenous recombinant 
protein into the intracellular space  
pEGFP9R and pEGFP-NI (as control) were transfected into 
293FT cells using the calcium phosphate transfection 
method. The two transfected cell cultures were then ultra-
sonically disrupted, and the extracts were filtered and con-
centrated through Amicon Ultra-15 (Millipore, Billerica, 
MA, USA). The cell lysate concentrate containing PTD- 
fused recombinant EGFP protein or non-PTD-fused EGFP 
protein was then added to cESC culture medium. Six hours 
later, EGFP signal was assessed under a fluorescence mi-
croscope to evaluate the efficiency of the PTD in translo-
cating exogenous recombinant protein into the intracellular 
space. 
1.3  Recombinant pluripotency protein production 
pPF9R-IRES plasmids were transfected into 293FT cells 
using the calcium phosphate transfection method. Approx-
imately 80 μg of each pPF9R-IRES plasmid was used to 
transfect 4×108 293FT cells. After three days, when a green 
fluorescence signal from the transfected 293FT cells was 
observed under a fluorescence microscope, cells were 
washed twice with PBS and then ultrasonically disrupted. 
Cell extracts were filtered and concentrated through 
Amicon Ultra-15 (Millipore) and subsequently stored at 
80°C. The presence of recombinant pluripotency proteins 
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in these cell extracts was evaluated by western blot analysis.  
1.4  Western blot analysis  
Concentrated cell extracts containing different recombinant 
pluripotency proteins were subjected to 12% SDS-    
polyacrylamide gel electrophoresis (PAGE) and transferred 
to PVDF membranes (Millipore). After blocking with a 
solution of dried skimmed milk, membranes were incubated 
with 1:1000 dilutions of the following primary antibodies: 
rabbit anti-human POUV antibody (R&D, Minneapolis, MN, 
USA), mouse anti-human Nanog antibody (R&D), rabbit 
anti-human Sox-2 antibody (R&D), and mouse anti-human 
Lin28 antibody (R&D). The membranes were then incubat-
ed with a 1:5000 dilution of the appropriate horseradish 
peroxidase-conjugated secondary antibody: goat anti-rabbit 
immunoglobulin G (IgG) (Kangchen, Beijing, China) and 
goat anti-rabbit immunoglobulin G (IgG) (Kangchen). De-
tection was proformed using an enhanced-chemilumines- 
cent substrate (Kangchen).   
1.5  Cell culture and addition of recombinant pluripo-
tency proteins 
Dulbecco’s modified Eagle’s medium (DMEM, Invitrogen, 
California, CA, USA), supplemented with 2 mmol L1 
L-glutamine (Invitrogen), 1 mmol L1 β-mercaptoethanol, 
1×non-essential amino acids (NEAA, Invitrogen), 10% fetal 
bovine serum (FBS, Hyclone, Thermo Scientific, Logan, 
UT, USA), 100 U mL1 penicillin, and 100 μg mL1 strep-
tomycin (Invitrogen) was used as a basic culture medium. 
cESCs were cultured in a 96-well culture dish using the 
basic culture medium, supplemented with each recombinant 
pluripotency protein at 1.2 μg mL1. Mouse LIF (R&D) and 
human bFGF (Invitrogen) were added at concentrations of 
1500 U mL1 and 1 ng mL1, respectively. 
1.6  Cell proliferation analysis 
To assess the proliferation of cells, we used Cell Counting 
Kit-8 (CCK-8, Dojindo Laboratories, Tokyo, Japan) and 
propidium iodide (PI) staining. The former tests for cell 
viability, as determined by the CCK-8 OD value, while the 
later tests for cell viability and cell apoptosis.  
1.7  Alkaline phosphatase reaction 
Cells were fixed with cold 4% paraformaldehyde for 15 min 
after washing with PBS several times. The AKP reaction 
was performed at 37°C for 30 min by adding 10 μL AKP 
staining solution (100 mmol L1 NaCl, 100 mmol L1 
Tris-HCl (pH 9.5), 5 mmol L1 MgCl2, 1 mg mL1 NBT, 
and 0.1 mg mL1 BCIP) to each well. The reaction was 
stopped by washing cells with PBS. 
1.8  Immunofluorescence analysis of SSEA-I 
After fixing with cold 4% paraformaldehyde for 15 min at 
room temperature, cells were blocked in 1% BSA, incubat-
ed with fluorescent isothiocyanate-conjugated human an-
ti-SSEA-I monoclonal antibody (R&D) diluted 1:500 in 
blocking agent for 1 h at room temperature, and then 
washed twice with PBS. Stained cells were observed under 
an inverted fluorescence microscope. 
1.9  Real-time RT-PCR analysis of pluripotency marker 
genes  
To analyze mRNA levels, cells were treated with TRIzol 
reagent (Invitrogen) and extracted total RNA was reverse 
transcribed. Real-time PCR analyses were then performed 
in triplicate using SYBR Green I and a DNA Engine Opti-
con (MJ Research, Waltham, Massachusetts, USA).  
1.10  Embryoid body formation by cultured cESCs  
After six generations, cultured cESCs were dissociated and 
cultured in suspension without any anti-differentiation fac-
tors on smooth surface dishes coated with 1% agarose gel to 
prevent cell adhesion to the plastic surfaces. 
1.11  Statistical analysis 
Results are reported as mean±standard error (SE). We tested 
the data for statistical significance using Student’s t-test. A 
P-value less than 0.05 was considered significant. All ex-
periments were repeated at least three times to ensure re-
producibility. 
2  Results 
2.1  The PTD fusion protein was efficiently translocat-
ed into the intracellular space of cESCs  
To test the efficiency of the nine consecutive arginine PTD 
to deliver proteins into cESCs, a PTD efficiency test vector, 
pEGFP9R, was constructed (Figure 1A, Table 1). 293FT 
cells were transfected with pEGFP9R, cultured and then 
ultrasonically disrupted. Isolated cell extracts, containing 
recombinant EGFP fused with the PTD, were added to 
cESCs culture media. 293FT cells were also transfected 
with pEGFP-NI and the expressed no-PTD-fusion EGFP 
protein was added in cESCs culture medium as a control. 
Based on fluorescence microscopy observations, approxi-
mately 70%80% of cESCs contained translocated recom-
binant EGFP, while translocation of the no-PTD-fused 
EGFP was not detected (Figure 1B). This indicated that the 
nine consecutive arginine PTD functioned with high effi-
ciency in delivering foreign proteins into the cytoplasm of 
cESCs. Thus, recombinant pluripotency proteins with a nine  
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Figure 1  Nine consecutive arginine PTD-fused-EGFP efficiently trans-
located into the intracellular space of cESCs. A, Schematic representation 
of the PTD efficiency test vector (pEGFP9R). EGFP was fused with a nine 
consecutive arginine sequence. A CMV promoter was used to drive the 
EGFP-PTD cassette. B, 293FT cell extract containing PTD-fused-EGFP 
(EGFP-9R) or 293FT cell extract containing no-PTD-fused EGFP (EGFP) 
was added to cESC culture media. Green fluorescence was observed under 
a fluorescence microscope 6 h later. Images are at 100× magnification. 
consecutive arginine PTD should be able to enter the cyto-
plasm of cultured cESCs. 
2.2  Production of recombinant pluripotency proteins 
and addition to cESC culture media 
Recombinant pluripotency protein expression vectors, 
pPF9R-IRES, were constructed (Figure 2A, Table 1), such 
that the pluripotency proteins were expressed synchronously 
with EGFP in transfected 293FT cells. By EGFP signal ob-
servation and Western blot analysis, the four recombinant 
pluripotency proteins were demonstrated to be expressed in 
293FT cells and to be contained in concentrated 293FT cell 
extracts (Figure 2B). 
 
Figure 2  PTD fused recombinant pluripotency factor expression vectors 
(pPF9R-IRES) and expression of recombinant pluripotency proteins. A, 
Schematic representation of pluripotency protein expression vector 
(pPF9R-IRES): the four pluripotency factors (Sox-2, POUV, Nanog and 
Lin28) were fused with a sequence of nine consecutive arginines. PF-PTD 
and EGFP coding sequences were separated by an internal ribosomal entry 
site (IRES) and expression was driven by a CMV promoter. B, Correct 
processing of each pluripotency protein was confirmed by Western blot 
analysis. a, extracts from 293FT cells transfected with the four different 
pPF9-IRES plasmids were reacted with antibodies against the four plurip-
otency factors; b, non-cultured X blastoderm cells were reacted with anti-
bodies against the four pluripotency factors; c, extracts from 293FT cells 
transfected with pEGFP-IRES2 were reacted with antibodies against the 
four pluripotency factors. 
2.3  Four recombinant pluripotency proteins inhibited 
differentiation of cESCs in vitro for three generations  
CCK-8 and PI tests showed that the four recombinant plu-
ripotency proteins inhibited the differentiation of cESCs. 
Cells cultured with the four pluripotency proteins sustained 
high proliferation rates in vitro for up to three generations 
(Figure 3A); however, after three generations, cells under-
went apoptosis or died, and no differentiated morphological 
shapes were observed (Figure 3B). Expression of pluripo-
tency marker genes was detected in cESCs before the third 
passage (Figure 3C), while expression of differentiation  
Table 1  Primers used to amplify EGFP and pluripotency protein coding sequencesa) 
Primer name Primer sequence 












Sox-2 9R sense 5′-CCGGAATTCCGCCACCATGATGGAAACCGAGCTGAAACC-3′ 
Sox-2 9R antisense 
5′-CGGGGATCC TTAGCGGCGTCTGCGTCTGCGGCGTCTGCGC 
ATATGTGATAGAGGGAGTG-3′ 
Lin28 9R sense 5′-CGGGGTACCGCCACCATGGGGTCTGTTTCCAACCAG-3′ 
Lin28 9R antisense 
5′-CGGGGATCCTCAGCGGCGTCTGCGTCTGCGGCGTCTGCGT 
TCCCGGGTTTCGGGGAGC-3′ 
a) Dashed underscore indicates sequence of endonuclease sites. Solid underscore indicates sequence of nine consecutive arginines. 
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Figure 3  Four recombination pluripotency proteins inhibit differentiation of cESCs in vitro for three generations. A, Viability of in vitro cultured cESCs 
was tested using CCK-8. , Medium containing the four pluripotency proteins (basic culture medium was supplemented with cell extracts from 293FT 
cells transfected with pPF9R-IRES plasmids); , control medium 1 (basic culture medium supplemented with cell extracts from 293FT cells transfected 
with pIRES2-EGFP); , control medium 2 (basic culture medium supplemented with cell extracts from 293FT cells without any plasmid transfection); , 
control medium 3 (basic culture medium: DMEM supplemented with 10% FBS). B, PI staining and morphological characteristics of cESCs cultured in vitro. 
, cESCs cultured in medium containing the four pluripotency proteins; , cESCs cultured in control medium 1; , cESCs cultured in control medium 2; 
, cESCs cultured in control medium 3. Images are 100× magnification. C, Expression of pluripotency marker genes in cESCs cultured in vitro. , cESCs 
passaged 03 times cultured in medium containing the four pluripotency proteins; , cESCs passaged 03 times cultured in control medium 1; , cESCs 
passaged 03 times cultured in control medium 2; , cESCs passaged 03 times cultured in control medium 3. D, Expression of differentiation marker 
genes in cESCs cultured in vitro. , cESCs passaged 03 times cultured in medium containing the four pluripotency proteins; , cESCs passaged 03 
times cultured in control medium 1; , cESCs passaged 03 times cultured in control medium 2; , cESCs passaged 03 times cultured in control medi-
um 3. 
marker genes was not detected (Figure 3D). These results 
showed that there was no tendency towards differentiation 
in cESCs cultured with the four recombinant pluripotency 
proteins. Control cultures were grown in three different me-
dia: basic medium containing pEGFP-IRES2 transfected 
293FT cell extracts, basic medium containing no plasmid- 
transfected 293FT cell extracts, and basic medium only. In 
these control media, proliferation rates of cultured cESCs 
were reduced after just one generation (Figure 3A) and dif-
ferentiated morphological shapes were observed after just 
one passage (Figure 3B). Moreover, in these cESCs, the 
expression of pluripotency marker genes was not detected 
after one passage (Figure 3C), while expression of differen-
tiation marker genes was detected after one passage (Figure 
3D). All of these observations suggest that the four pluripo-
tency proteins inhibited in vitro differentiation of cultured 
cESCs for three generations. 
2.4  Four recombinant pluripotency proteins combined 
with LIF and bFGF promoted the proliferation of 
cESCs for seven generations and typical pluripotency 
characteristics were maintained  
To prolong the culture time of cESCs, mouse cytokine, LIF, 
and human growth factor, bFGF, were added to the culture 
medium, because they have the ability to promote prolifera-
tion of mESCs and hESCs. CCK-8 results indicated that 
cESCs cultured with a combination of the four pluripotency 
factors, LIF and bFGF could proliferate in vitro for seven 
generations. Media containing the four pluripotency pro-
teins and either LIF or bFGF could promote proliferation of 
cultured cESCs for five generations, while media containing 
only LIF and bFGF could promote proliferation for just 
three generations (Figure 4A). Moreover, the pluripotency 
assays, SSEA-I immunofluorescence staining and AKP re-
action staining, showed that cESCs cultured with the four 
pluripotency proteins, LIF, and bFGF still expressed the 
ESC-specific surface antigen, SSEA-I, and endogenous 
AKP even after seven passages (Figure 4B). In comparison, 
cESCs cultured with LIF and bFGF only were negative for 
the two pluripotency markers after three passages and, to-
gether with the morphological images of these cells, these 
results indicated that cESCs cultured with only LIF and 
bFGF lost pluripotency characteristics and underwent dif-
ferentiation after just one passage (Figure 4C). Quantitative 
RT-PCR (Table 2) showed that the mRNA levels of endog-
enous pluripotency genes, such as POUV, Nanog, Sox-2, 
Lin28 and C-Myc, were not diminished in cultured cESCs 
until the 7th passage, when a rapid decline of Lin28 expres-
sion occurred. This decrease was followed by decreases in 
the expression of the other four genes and a stop in prolifer-
ation (Figure 4D). These results demonstrated that the four 
recombinant pluripotency proteins combined with LIF and 
bFGF could maintain pluripotency of cESCs in vitro and 
support their proliferation for seven generations.
46 Yu M Y, et al.   Sci China Life Sci   January (2013) Vol.56 No.1 
 
Figure 4  Four recombination pluripotency proteins combined with LIF and bFGF promoted the proliferation of cESCs for seven generations and typical 
pluripotency characteristics were maintained. A, Viability of cultured cESCs was tested using CCK-8. , Four pluripotency proteins and 
LIF; , four pluripotency proteins and bFGF; , four pluripotency proteins, LIF and bFGF; , LIF and bFGF only. B, cESCs 
cultured for 0, 6, and 7 passages with pluripotency proteins, LIF, and bFGF were used to assess morphology, AKP activity, and SSEA-I 
expression to determine pluripotency. Images are 100× magnification. C, cESCs cultured for 1, 2, and 3 passages with LIF and bFGF only. 
Morphology, AKP activity, and SSEA-I expression were assessed to determine pluripotency. Images are 100× magnification. D, mRNA 
levels of pluripotency genes in cESCs cultured for 7 passages with the four recombinant pluripotency proteins, LIF, and bFGF were as-
sessed by quantitative RT-PCR.  
Table 2  Primers used to quantitative RT-PCR amplify pluripotency marker genes 
Primer name Primer sequence 
POUV sense 5′-AAAGGATTGCGAAATGCCCG-3′ 
POUV antisense 5′-CTGAGTGAAGCCCAGCATGA-3′ 
Nanog sense 5′-ATCCGTTCATGGCTGTGGAG-3′ 
Nanog antisense 5′-CTGATGCCGTACAGGAGAGC-3′ 
Sox-2 sense 5′-CTGGACCAACGGAGGCTATG-3′ 
Sox-2 antisense 5′-AGACGAGGAGGTGACTACGG-3′ 
Lin28 sense 5′-AGGTTTGGAATCCATCCGGG-3′ 
Lin28 antisense 5′-AGCTGTGCATGTCCTCCTTC-3′ 
C-Myc sense 5′-TTCCATCGGTCAGGACACAG-3′ 
C-Myc antisense 5′-TCATTACGCCTCTGACGCTC-3′ 
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2.5  cESCs cultured for six passages still maintained 
differentiation potential and telomerase activity 
Maintaining the ability to differentiate into cells of the three 
embryonic germ layers is the most significant evidence pos-
sible to demonstrate ESC pluripotency. In our study, cESCs 
cultured for six generations exhibited the ability to differen-
tiate into cells of the three embryonic germ layers through 
EB formation. cESCs cultured for six generations, and then 
put into a suspension culture environment for four days re-
sulted in the generation of several EB structures (Figure 5A). 
Expression of differentiation genes by the formed EB 
structures was detected by RT-PCR (Table 3). Cells of all 
three embryonic germ layers are represented by expression 
of these genes (Figure 5B), including endoderm derivatives 
(APF, GATA6, GATA4), mesoderm derivatives (Brachyury, 
CD34, NKX2-5), and ectoderm derivatives (Vasa, VE- 
cadherin, Cdx-2). Immortality is another significant proper-
ty of ESC pluripotency, which relies on telomerase activity 
to prevent telomere shortening. Telomerase reverse tran- 
scriptase (TERT) expression is often used as an estimate of 
telomerase activity. In our study, telomerase activity in 
cESCs cultured from zero to six passages was assessed by 
assaying TERT expression at the mRNA level using 
RT-PCR. The results demonstrated that telomerase activity 
in our cultured cESCs remained positive as passage number 
increased (Figure 5C). These results indicated that cultured 
cESCs were still pluripotent after six generations and that 
they exhibited the potential to be cultured for a longer 
times. 
3  Discussion 
Pluripotency factors have not previously been reported to be 
used in culturing ESCs. Here we consider the difficulties of 
using pluripotency factors as part of a culture medium. By 
observing recombinant EGFP protein, the sequence of nine 
consecutive arginines was demonstrated to be a highly effi- 
 
 
Figure 5  Ability of cESCs to differentiate into cells of the three embryonic layers in vitro. A, cESCs cultured in vitro formed three-dimensional, multicel-
lular spheroid aggregates of EB structures by the 6th generation. Images are 100× magnification. B, Expression analysis of differentiation genes using total 
RNA extracted from EB formations and primers of genes expressed in the three embryonic germ layers, β-actin was employed as a control. C, TERT expres-
sion was detected by RT-PCR of cESCs passaged 06 times in the presence of the four recombinant pluripotency proteins to determine telomerase activity, 
β-actin was employed as a control. D, TERT expression was assayed by RT-PCR in chicken embryonic fibroblast cells (cEFCs) and in differentiated cells 
from cESCs cultured in control media in the absence of recombinant pluripotency proteins to determine telomerase activity, β-actin was employed as a con-
trol. 
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Table 3  Primers used to amplify genes expressed in cells associated with the three embryonic germ layers, TRET, and β-actin 
Primer name Primer sequence 
AFP sense (endoderm derivatives) 5′-CCTGACATCGAGGTGATCCT-3′ 
AFP antisense (endoderm derivatives) 5′-CAAAGAGACCCAGCAGGAAG-3′  
Gata6 sense (endoderm derivatives) 5′-CCGACCACTTGCTATGAAAAA-3′ 
Gata6 antisense (endoderm derivatives) 5′-CAGCCCATCTTGACCTGAATA-3′ 
Gata4 sense (endoderm derivatives) 5′-TGAGAAAAGAGGGCATTCAGA-3′ 
Gata4 antisense (endoderm derivatives) 5′-GCAGGATGAATTGAAGATCCA-3′ 
NKX2-5 sense (mesoderm derivatives) 5′-CCTTCCCCGGCCCCTACTAC-3′ 
NKX2-5 antisense (mesoderm derivatives) 5′-CTGCTGCTTGAACCTTCTCT-3′ 
BRACHYURY sense (mesoderm derivatives) 5′-ACGCCATGTACTCCTTCCTG-3′ 
BRACHYURY antisense (mesoderm derivatives) 5′-TGTTGGTGAGCTTGACCTTG-3′ 
CD34 sense (mesoderm derivatives) 5′-ACCATGGGTTCCAGCACTAC-3′ 
CD34 antisense (mesoderm derivatives) 5′-TGCTTGTGTTCTCTGGATGC-3′ 
Vasa sense (ectoderm derivatives) 5′-TGTGGCAACTTCGGTAGCAT-3′ 
Vasa antisense (ectoderm derivatives) 5′-TGGACAGCCATTCTTCCACC-3′ 
VE-Cadherin sense (ectoderm derivatives) 5′-TCTTGGCTCCAGCATTCTCT-3′ 
VE-Cadherin antisense (ectoderm derivatives) 5′-CCATCGTACCCTTGCACTTT-3′ 
Cdx2 sense (ectoderm derivatives) 5′-TCAAAACCAGGACGAAGGAC-3′ 
Cdx2 antisense (ectoderm derivatives) 5′-CCAGATTTTCACCTGCCTCT-3′ 
TRET sense  5′-GCCATCCCCAGGGTTTGTTA-3′ 
TRET antisense 5′-ACGTGCAGTAACAGTGCTGA-3′ 
β-actin sense 5′-TTACCCACACTGTGCCCATC-3′ 
β-actin antisense 5′-TGACCTGACCATCAGGGAGT 
 
cient tool to translocate fusion proteins into the intracellular 
space of cESCs. This correlated with previous reports from 
medical and pharmacology studies showing that many 
medical proteins conjugated with PTDs, such as HIV-1 Tat  
or poly-hydrophobic amino acids, can be delivered into 
cells and remain functionally intact, with efficiencies of 
about 70%90% [1622]. The 70%80% efficiency of the 
nine consecutive arginine PTD used here is comparable to 
these previously reported efficiencies. The pluripotency 
factors in the form of recombinant proteins fused with nine 
consecutive arginines could be used to maintain pluripo-
tency of cESCs in vitro. 
In our study, cESCs cultured with the four recombinant 
pluripotency proteins did not show any differentiation after 
three generations of culture, neither in morphological shape 
nor in the expression of marker genes. In contrast, cESCs 
expressed pluripotency genes until the third generation, 
when they underwent apoptosis or died, indicating that dif-
ferentiation was inhibited by the recombinant pluripotency 
proteins. The requirement for LIF and bFGF reflected the 
function of the two factors in promoting proliferation of 
undifferentiated cESCs [2329]. However, cESCs cultured 
with a combination of mouse LIF and human bFGF only did 
not exhibit any positive effect on pluripotency maintenance. 
This observation was in line with previous studies reporting 
that cESCs cultured with mouse LIF and human bFGF un-
derwent differentiation after just one passage and indicates 
that the two factors alone were not as functional in main-
taining cESC pluripotency as they were in maintaining 
mESC and hESC pluripotency [4,23]. A combination of the 
four recombinant pluripotency proteins with LIF and bFGF 
showed a powerful ability to support cESC proliferation for 
at least seven generations. In addition, the time interval be-
tween generations was shorter, indicating that cESCs be-
came more vigorous in medium containing both pluripo-
tency proteins and the two factors. These results demon-
strated that the four pluripotency proteins complement the 
function of LIF and bFGF as promoters of proliferation and 
supporters of cESC pluripotency in vitro. Most genes 
downstream of LIF and bFGF are the same as those down-
stream of the pluripotency factors [3032]. In addition, the-
se downstream genes always undergo epigenetic changes 
before they are regulated by LIF or bFGF [3337]. The 
ability of the LIF or bFGF to promote proliferation could be 
a result of the maintenance of pluripotency by the added 
pluripotency proteins, which provided an appropriate epi-
genetic environment for their signaling pathways to con-
verge and work together. In another respect, the requirement 
of LIF and bFGF may also reflect an insufficient level of 
pluripotency proteins, which may have been limited by the 
total volume that can be held by a culture plate well. There 
may not have been sufficient pluripotency factors added to 
the cESC culture medium to fully support both pluripotency 
and self-renewal, indicating that additional pluripotency 
proteins might substitute the need for LIF and bFGF. In 
addition, positive staining for SSEA-I and AKP activity, as 
well as the expression of pluripotency genes demonstrated 
the pluripotency of cESCs cultured for six generations. 
Thus, addition of pluripotency proteins provides a direct 
and useful way to maintain pluripotency of cESCs in vitro. 
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With some improvements, the proliferation of cultured cells 
could be promoted for a longer time.  
Assessment of differentiation ability and telomerase ac-
tivity provided further convincing evidence of the cultured 
cESCs’ pluripotency and demonstrated the possibility of 
generating a long-term cESC line using the four recombi-
nant pluripotency proteins. EB structures were formed by 
cESCs cultured after six generations, and contained various 
differentiated cells derived from all three embryonic germ 
layers. Although the EB structure is far from a real embry-
onic structure in organization and function, this in vitro dif-
ferentiation test indicated that cESCs of at least six genera-
tions have the potential to differentiate into cells of all three 
embryonic germ layers. Telomerase activity reflects the 
immortality of cESC and is routinely tested as a determina-
tion of pluripotency and self-renewal. TERT is an important 
catalytic subunit of telomerase and is considered as a mark-
er of telomerase activity [38,39]. TERT expression in cul-
tured cESCs showed consistent telomerase activity from 
zero to six generations, indicating the maintenance of te-
lomerase activity in cultured cESCs. 
Pluripotency factors have been reported to function in 
differentiation inhibition, the maintenance of the open state 
of chromatin, and protection of the unique short cell cycle 
of ESCs [4044]. POUV inhibits ESCs from differentiating 
into ectoderm cells [45], while Sox-2 forms a temporary 
complex with POUV when regulating the cell cycle and 
chromatin state through downstream target genes [46,47]. 
Levels of Nanog are considered to be a switch leading ESCs 
to rapidly choose between self-renewal and differentiation 
[48]. Here, Lin28 exhibited an essential role in cESCs based 
on the results of pluripotency gene expression tests. In these 
tests, genes were steadily expressed until the seventh gener-
ation, when a decrease of Lin28 expression was detected. 
This was followed by a decrease in the expression of other 
pluripotency genes and the termination of cESC prolifera-
tion. Lin28 is a blocker of the mRNA Let-7 maturation pro-
cess. Mature Let-7 binds to mRNAs of target genes in-
volved in cell cycle facilitation, telomerase activity protec-
tion, and chromatin reconstruction and silences their ex-
pression [4952]. Lin28 was also reported to stabilize these 
mRNAs and increase their expression [5357]. Therefore, 
Lin28 could be viewed as a pluripotency factor and an epi-
genetic factor. It has been widely demonstrated and accept-
ed that when cell cycle progression of cultured ESCs is 
blocked, chromatin structure condenses, and a series gene 
expression changes occur allowing ESCs to undergo differ-
entiation or apoptosis [5861]. Therefore, Lin28, by linking 
epigenetic status and cell cycle progression of ESCs with 
pluripotency and self-renewal, should be a central focus for 
ESC research. 
Taken together, chickens offer numerous advantages as 
transgenic animals for medical, pharmacological and bio-
technology research. The generation of a long-term cESC 
line in vitro has become increasingly necessary. Such a cell 
line should be stable, highly proliferative, immortal, easily 
used, and consistent. In this study, a new culture system was 
developed, being the first to introduce pluripotency factors 
into the cESC culture method. We have shown the ability of 
the novel system to maintain the pluripotency of cESCs for 
at least six generations in vitro and to provide a relatively 
stable and large number of cells for genetic engineering and 
other areas of cESC research. The results of this study, to-
gether with previous iPSCs reports, demonstrate that ample 
expression of pluripotency factors are the key to pluripo-
tency and self-renewal of ESCs. With further improvements, 
a long-term cESC line could be developed in vitro based on 
this method.  
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